[go: up one dir, main page]

IT1119853B - Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie - Google Patents

Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie

Info

Publication number
IT1119853B
IT1119853B IT50331/79A IT5033179A IT1119853B IT 1119853 B IT1119853 B IT 1119853B IT 50331/79 A IT50331/79 A IT 50331/79A IT 5033179 A IT5033179 A IT 5033179A IT 1119853 B IT1119853 B IT 1119853B
Authority
IT
Italy
Prior art keywords
proteinemie
hyperlipo
dyslipidemia
carnitine
treatment
Prior art date
Application number
IT50331/79A
Other languages
English (en)
Other versions
IT7950331A0 (it
Inventor
Maria Teresa Ramacci
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT50331/79A priority Critical patent/IT1119853B/it
Publication of IT7950331A0 publication Critical patent/IT7950331A0/it
Priority to US06/187,655 priority patent/US4315944A/en
Priority to BE0/202149A priority patent/BE885290A/fr
Priority to CH699980A priority patent/CH644268A5/it
Priority to GB8030373A priority patent/GB2058566A/en
Priority to FR8020249A priority patent/FR2465480A1/fr
Priority to DE19803035494 priority patent/DE3035494A1/de
Application granted granted Critical
Publication of IT1119853B publication Critical patent/IT1119853B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT50331/79A 1979-09-21 1979-09-21 Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie IT1119853B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT50331/79A IT1119853B (it) 1979-09-21 1979-09-21 Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie
US06/187,655 US4315944A (en) 1979-09-21 1980-09-16 Pharmaceutical composition comprising L-carnitine for the treatment of hyperlipidaemias and hyperlipoproteinaemias
BE0/202149A BE885290A (fr) 1979-09-21 1980-09-18 Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies
CH699980A CH644268A5 (it) 1979-09-21 1980-09-18 Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipoproteinemie.
GB8030373A GB2058566A (en) 1979-09-21 1980-09-19 Pharmaceutical composition comprising L-carnitine
FR8020249A FR2465480A1 (fr) 1979-09-21 1980-09-19 Composition pharmaceutique contenant de la l-carnitine pour le traitement des hyperlipidemies et des hyperlipoproteines
DE19803035494 DE3035494A1 (de) 1979-09-21 1980-09-19 Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT50331/79A IT1119853B (it) 1979-09-21 1979-09-21 Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie

Publications (2)

Publication Number Publication Date
IT7950331A0 IT7950331A0 (it) 1979-09-21
IT1119853B true IT1119853B (it) 1986-03-10

Family

ID=11272753

Family Applications (1)

Application Number Title Priority Date Filing Date
IT50331/79A IT1119853B (it) 1979-09-21 1979-09-21 Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie

Country Status (6)

Country Link
US (1) US4315944A (it)
BE (1) BE885290A (it)
CH (1) CH644268A5 (it)
DE (1) DE3035494A1 (it)
FR (1) FR2465480A1 (it)
IT (1) IT1119853B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1119854B (it) * 1979-09-21 1986-03-10 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
JP3790767B2 (ja) * 2004-06-30 2006-06-28 森下仁丹株式会社 脂肪代謝改善組成物
US20070116713A1 (en) * 2005-11-22 2007-05-24 Gill Robert P Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
WO2008018877A1 (en) * 2006-08-11 2008-02-14 Ssv Therapeutics, Inc. Carnitine conjugates as dual prodrugs, methods of production and uses thereof
US8904479B1 (en) 2008-03-28 2014-12-02 Google Inc. Pattern-based mobile device unlocking

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE661015A (it) * 1965-03-12 1965-09-13
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin

Also Published As

Publication number Publication date
DE3035494A1 (de) 1981-04-09
BE885290A (fr) 1981-01-16
FR2465480A1 (fr) 1981-03-27
CH644268A5 (it) 1984-07-31
IT7950331A0 (it) 1979-09-21
US4315944A (en) 1982-02-16

Similar Documents

Publication Publication Date Title
IT1134636B (it) Procedimento e composizione per la preparazione di farmaceutici controllati a lunga azione
BE890192A (fr) Compositions et procede pharmaceutiques
IT7948816A0 (it) Esteri e ammidi di acil carnitine loro procedimenti di preparazione eloro uso terapeutico
IT7967650A0 (it) Procedimento per la preparazione delle acril e metacril ammidi n.sostituite
IT1143009B (it) Composti farmaceutici ad azione antisecretiva e procedimento di preparazione
IT8348294A0 (it) Composti e composizioni per il trattamento delle affezioni cardiocircolatorie e procedimento di preparazione
IT1119853B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
JPS56139442A (en) Acyl derivative of carnitine, manufacture and medicine as effective ingredient thereof
GB2057872B (en) Use of glycerylphosphoryl derivatives in the therapy of dislipaemia hepatitis and like pathological conditions and pharmaceutical compositions therefor
IT1119854B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
MX7159E (es) Procedimiento para la preparacion de 2-amino-3-benzoil fenilacetamidas y homologos ciclicos
PT82765A (pt) Processo para a preparacao de factor supressor activante e de composicoes farmaceuticas para o tratamento de doencas auto-imines
PH16250A (en) Pharmaceutical composition of therapeutic value in the treatment of some shock conditions
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
IT8019228A0 (it) Medicamento per la prevenzione ed il trattamento della cirrosi epatica.
IT7869700A0 (it) Medicamento per il trattamento dell'ateroma e delle angiopatie
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
IT1113332B (it) Procedimento per la preparazione di clorozocitina e relative formulazioni farmaceutiche
IT1187666B (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
IT1112479B (it) Composizione farmaceutica particolarmente atta alla terapia di enteriti e di affezioni diarroiche generiche
IT8068360A0 (it) Preparato medicinale per il trattamento di disturbi ipotonici e di disfunzioni circolatorie ortostati che
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
DE3028506A1 (de) Pharmaceutical composition and process for the preparation thereof

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970709